Evidence map›Paper›PMID 32316388›Full record

ArticleCancers2020

Ex Vivo Assessment of Tumor-Targeting Fluorescent Tracers for Image-Guided Surgery.

Fortuné M K Elekonawo, Jan Marie de Gooyer, Desirée L Bos, David M Goldenberg, Otto C Boerman, Lodewijk A A Brosens, Andreas J A Bremers, Johannes H W de Wilt, Mark Rijpkema

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Targeted optical fluorescence imaging: a meta-narrative review and future perspectives.European journal of nuclear medicine and molecular imaging · 2021
    Review
  6. High-ResolutionJournal of clinical medicine · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Fortuné M K ElekonawoDepartment of Radiology, Nuclear Medicine and Anatomy, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.ORCID 0000-0002-1726-186X
Jan Marie de GooyerDepartment of Radiology, Nuclear Medicine and Anatomy, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.ORCID 0000-0002-4636-5617
Desirée L BosDepartment of Radiology, Nuclear Medicine and Anatomy, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.
David M GoldenbergCenter for Molecular Medicine and Immunology, Mendham, NJ 07945, USA.
Otto C BoermanDepartment of Surgery, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.
Lodewijk A A BrosensDepartment of Pathology, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.ORCID 0000-0003-1341-8994
Andreas J A BremersDepartment of Surgery, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.
Johannes H W de WiltDepartment of Surgery, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.
Mark RijpkemaDepartment of Radiology, Nuclear Medicine and Anatomy, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525GA Nijmegen, The Netherlands.
Radboud University Nijmegen · NLCenter for Molecular Medicine and Immunology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Image-guided surgery can aid in achieving complete tumor resection. The development and assessment of tumor-targeted imaging probes for near-infrared fluorescence image-guided surgery relies mainly on preclinical models, but the translation to clinical use remains challenging. In the current study, we introduce and evaluate the application of a dual-labelled tumor-targeting antibody for ex vivo incubation of freshly resected human tumor specimens and assessed the tumor-to-adjacent tissue ratio of the detectable signals. Immediately after surgical resection, peritoneal tumors of colorectal origin were placed in cold medium. Subsequently, tumors were incubated with

Indexed as

antibodycolorectal cancerex vivoimage-guided surgerytargeted imaging near infrared fluorescencetranslational medicine

Identifiers

PMID32316388
PMCPMC7226456
OpenAlexW3016763063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.